The largest database of trusted experimental protocols
> Chemicals & Drugs > Amino Acid > Protein phosphatase inhibitor-2

Protein phosphatase inhibitor-2

Protein Phosphatase Inhibitor-2 is a regulatory protein that inhibits the activity of protein phosphatase enzymes, particularly protein phosphatase 1 (PP1).
It plays a key role in the regulation of cellular processes such as glycogen metabolism, transcription, and cell cycle control.
Inhibitor-2 binds to the catalytic subunit of PP1, preventing its activity and leading to the phosphoryaltion of PP1 substrates.
This protein is important in maintaining the balance between phosphorylation and dephosphorylation within the cell.
Dysregulation of Protein Phosphatase Inhibitor-2 has been implicated in various pathological conditions, including diabetes, cancer, and neurological disorders.
Understanding the functional role and regulation of this inhibitor is crucial for developing targeted therapeutic strategies.

Most cited protocols related to «Protein phosphatase inhibitor-2»

The MCF-7 cell line was maintained under standard conditions in Dulbecco's modified Eagle's medium supplemented with 10% foetal bovine serum. Cells were washed with ice cold phosphate buffered Saline and lysed in RIPA buffer (1% NP-40, 0.1% SDS, 0.5% Sodium deoxycholate, 50 mM Tris pH 7.5, 150 mM NaCl) supplemented with protease and phosphatase inhibitor cocktails (Sigma Aldrich) and protein concentration was quantitated by BCA protein assay (Invitrogen). Purified BSA (Applichem) was dissolved in RIPA buffer. Cell lysates and a BSA sample were serially diluted 1∶2 and run on SDS-PAGE using a standard protocol. Proteins were transferred to the PVDF (for ECL based detection) or Nitrocellulose (for LI-COR based proteins detection) membranes. Membranes were blocked with blocking solution (11500694001, Roche) for BSA detection or 5% skimmed milk for rest of the membranes. For Western blotting ERK (M-5670, Sigma Aldrich), mTOR (2972, Cell Signaling Technology), RSK1 (sc-231, Santa Cruz) and BSA (sc-50528, Santa Cruz) antibodies were used. Anti-rabbit HRP-conjugated (Cell Signaling Technology) or anti-Rabbit IR 800 (LI-COR) secondary antibodies were used for ECL or LI-COR protein detection systems, respectively. Signal was detected by standard X-ray films (Fuji), CCD camera (Advanced Molecular Vision) or LI-COR scanner.
Full text: Click here
Publication 2014
Antibodies Biological Assay Buffers Cells Cold Temperature Deoxycholic Acid, Monosodium Salt Fetal Bovine Serum FRAP1 protein, human MCF-7 Cells Milk, Cow's Nitrocellulose Nonidet P-40 Peptide Hydrolases Phosphates Phosphoric Monoester Hydrolases polyvinylidene fluoride Proteins Rabbits Radioimmunoprecipitation Assay RPS6KA1 protein, human Saline Solution SDS-PAGE Sodium Chloride Tissue, Membrane Tromethamine Vision X-Ray Film
Human brain tissues from four sporadic AD patients, three Down syndrome patients with abundant tau pathology qualified for AD (referred to as AD/DS), and two normal controls were used in this study (Table S1). All cases used were histologically confirmed. Two of the AD/DS cases were provided by the University of Washington brain bank. The use of postmortem brain tissues for research was approved by the University of Pennsylvania’s Institutional Review Board with informed consent from patients or their families. For each purification, 6–14 g of frontal cortical gray matter was homogenized using a Dounce homogenizer in nine volumes (v/w) of high-salt buffer (10 mM Tris-HCl, pH 7.4, 0.8 M NaCl, 1 mM EDTA, and 2 mM dithiothreitol [DTT], with protease inhibitor cocktail, phosphatase inhibitor, and PMSF) with 0.1% sarkosyl and 10% sucrose added and centrifuged at 10,000 g for 10 min at 4°C. Pellets were reextracted once or twice using the same buffer conditions as the starting materials, and the supernatants from all two to three initial extractions were filtered and pooled. Additional sarkosyl was added to the pooled low-speed supernatant to reach 1%. After 1-h nutation at room temperature, samples were centrifuged again at 300,000 g for 60 min at 4°C. The resulted 1% sarkosyl-insoluble pellets, which contain pathological tau, were washed once in PBS and then resuspended in PBS (∼100 µl/g gray matter) by passing through 27-G 0.5-in. needles. The resuspended sarkosyl-insoluble pellets were further purified by a brief sonication (20 pulses at ∼0.5 s/pulse) using a hand-held probe (QSonica) followed by centrifugation at 100,000 g for 30 min at 4°C, whereby the majority of protein contaminants were partitioned into the supernatant, with 60–70% of tau remaining in the pellet fraction. The pellets were resuspended in PBS at one fifth to one half of the precentrifugation volume, sonicated with 20–60 short pulses (∼0.5 s/pulse), and spun at 10,000 g for 30 min at 4°C to remove large debris. The final supernatants, which contained enriched AD PHFs, were used in the study and referred to as AD-tau. In a subset of the experiments, the samples were boiled for 10 min right before the final 10,000-g spin to get rid of contaminating protease activity. The same purification protocol was used to prepare brain extracts from the two normal controls. The different fractions from PHF purification were characterized by Ponceau S staining, Western blotting (refer to Table S3 for antibodies), and sandwich ELISA for tau. The final supernatant fraction was further analyzed by transmission EM, BCA assay (Thermo Fisher Scientific), silver staining (SilverQuest Silver Staining kit; Thermo Fisher Scientific), and sandwich ELISA for Aβ 1–40, Aβ 1–42, and α-syn. The frontal cortex from one AD/DS case was purified using the traditional procedure with sucrose gradient fractionation as previously reported (Boluda et al., 2015 (link)). Enriched AD PHFs prepared using both methods showed similar seeding activity in primary hippocampal neurons from CD1 (non-Tg) mice.
Publication 2016
Antibodies ARID1A protein, human Autopsy Biological Assay Brain Buffers Centrifugation Cortex, Cerebral Dithiothreitol Down Syndrome Edetic Acid Enzyme-Linked Immunosorbent Assay Ethics Committees, Research Fractionation, Chemical Gray Matter Homo sapiens Lobe, Frontal Mice, Laboratory Needles Neurons Patients Pellets, Drug Peptide Hydrolases Phosphoric Monoester Hydrolases ponceau S Protease Inhibitors Proteins Pulse Rate Pulses Sodium Chloride sodium lauroyl sarcosinate Sucrose Tissues Transmission, Communicable Disease Tromethamine

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2014

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2016
bicinchoninic acid Brain Buffers Cold Temperature Dithiothreitol Freezing Iodoacetamide lysyl endopeptidase Nucleic Acids Peptide Hydrolases Peptides Phosphoric Monoester Hydrolases Promega Proteins SDS-PAGE Sep-Pak C18 Stainless Steel Tissues Trypsin Urea Vacuum
PC3-LN4 cultured cells were transfected as described above for TUNEL analysis. Cells were split as needed and collected at 24, 48, and 72 h post-transfection using trypsin. The cell pellets were frozen at −20°C immediately following collection. For immunoblot analysis, cell pellets were resuspended in 150 μl of RIPA lysis buffer (150 mM NaCl, 50 mM Tris–HCl (pH 7.5), 1% Igepal CA630, 0.5% deoxycholate, 0.1% sodium dodecyl sulfate, 10% glycerol) with the addition of Sigma protease (P8340) and phosphatase (P2850) inhibitor cocktails (used 1:100). The lysate was frozen at −70°C for 10 min, thawed on ice, vortexed for 5 s, and centrifuged for 5 min at 18,000×g and 4°C in a microcentrifuge. The supernatant was transferred to a fresh tube on ice, and quantitated using Bio-Rad protein assay reagent (500-0006). Equal quantities of lysates were separated in a 10% Tris–Glycine–SDS polyacrylamide gel by electrophoresis, and transferred to nitrocellulose membrane (Whatman 10 402 495) using the wet transfer method in Tris–Glycine–20% methanol. The membranes were blocked for 30 min with 5% nonfat milk (Bio-Rad 170-6404) in Tris-buffered saline (TBS, pH 7.4) with 0.1% Tween 20 (TBS-T) at room temperature. The membranes were then incubated overnight rocking at 4°C in 5% milk/TBS-T containing primary antibody. After washing 3 × 10 min in TBS-T, the membranes were incubated with secondary antibody in 5% milk/TBS-T for 1 h at room temperature and washed in TBS-T as before. Proteins were detected by enhanced chemiluminescence using Pierce SuperSignal West Pico and Dura substrates (Pierce 34078, 34076) and Blue Lite autorad film (ISC BioExpress F-9024-8×10).
Approximately 0.1 mg of tumor tissue was minced then homogenized into 1 ml of cytoskeleton (CSK) buffer and nuclear matrix was prepared as previously described using method C [18 (link)] with the following modifications. The homogenates were not filtered, and the final nuclear matrix pellets were resuspended in 250 μl RIPA lysis buffer and incubated on ice with repeated vortexing for 30 min. The suspension was centrifuged for 10 min at 18,000×g and the supernatant was transferred to a fresh 1.5 ml tube. Quantitations of cytosol and nuclear matrix were performed with the addition of H2O2 as described previously [63 (link)]. Cell fractions (20 μg of cytosol, 15 μg of nuclear matrix) were precipitated by addition of 3–5 volumes of −20°C acetone/methanol (1:1), vortex mixing, and centrifugation for 15 min at 18,000×g and 4°C. The pellet was washed with 0.5 ml −20°C methanol and centrifuged for 10 min at 18,000×g and 4°C. The protein pellet was resuspended in 20 μl of Novex loading buffer with tris(2-carboxyethyl)phosphine (TCEP) in RIPA buffer (each diluted to 1× concentration), the samples were heated at 37°C for 10 min, vortexed, and electrophoresed through NuPage 4-12% Bis–Tris 20 well gels (Invitrogen WG1402A) using MOPS SDS running buffer (Invitrogen NP0001). The gels were transferred to nitrocellulose membrane using the wet transfer method in Tris–Glycine–20% methanol. Protein detection was performed as above.
Antibodies used were Actin (sc-1616) and LDH-A (sc-27230) from Santa Cruz Biotechnology; CK2α (A300-197A) and CK2α′ (A300-199A) from Bethyl Laboratories; Casein Kinase II α/α′ from BD Transduction Laboratories (611611); CK2β (218712) from Calbiochem; Lamin B1 (33-2000) from Invitrogen; NF-κB p65 (610868) from BD Transduction Laboratories; Akt (9272) and Phospho-Akt Ser473 (9271) from Cell Signaling. Please note that in Fig. 1a, a chicken polyclonal anti-CK2αα′β antibody was used [64 (link)], however, because following this experiment this antibody was no longer functional, all subsequent immunoblots shown for CK2αα′ used the Bethyl Laboratories antibodies.
Publication 2011

Most recents protocols related to «Protein phosphatase inhibitor-2»

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2024

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2024
Not available on PMC !
Whole-cell extracts were lysed in IP buffer (Beyotime, P0013, Shanghai, China), which contained 1× protease inhibitor (K1007, APExBIO) and 1× Phosphatase inhibitor (K1015, APExBIO). The protein concentration was detected and diluted to a nal concentration of 000 ng/μL after ultrasonication. Firstly, the supernatants were incubated with protein G Plus-Agarose Immunoprecipitation reagent (sc-2003, Santa Cruz) for 2 h to remove unless speci cally bound proteins. The Plus-Agarose Immunoprecipitation reagent was removed and incubated with NLRP3 antibodies (1:200) overnight at 4℃. The next day, protein G Plus-Agarose Immunoprecipitation reagent was added to the supernatants overnight at 4℃. Afterwards, all beads were washed three times with PBS which contained 1× protease inhibitor and 1× Phosphatase inhibitor. Then 2× loading buffer was added to each sample and boiled at 100°C for 5 min followed by western blotting.
Publication 2024
Mice were sacrificed by cervical dislocation. Brains were removed and the somatosensory cortex (+0.38 mm to −1.94 mm anteroposterior from Bregma) was isolated. Tissues were snap-frozen and stored at −80°C. Defrosted samples were sonicated for 10 sec (QSonica CL-18; 1 sec alternating on/off pulses, 40% pulse amplitude) in ice-cold buffer containing: 320 mM Sucrose, 10 mM EDTA, 50 mM Tris pH 7.4, protease inhibitor (cOmplete mini, Roche), Phosphatase Inhibitor Cocktail 2 (Sigma-Aldrich), Phosphatase Inhibitor Cocktail 3 (Sigma-Aldrich). Samples were centrifuged (Sigma 4–16KS, 12 130 rotor) at 1500×g for 20 min at 4°C. The supernatant was transferred to a new tube and centrifuged for 30 min at 16 000×g at 4°C. The supernatant was removed, and the pellet was resuspended in 50 mM Tris containing phosphatase and protease inhibitors (TPP). Protein concentration was measured using a BCA protein assay and samples were normalized to 1 mg/ml in TPP.
Full text: Click here
Publication 2024
Total testis lysates were prepared as described above but phosphatase inhibitors were omitted. Each pair of testes from one juvenile male mouse was lysed in 50 µL 1x lysis buffer. After 1.5 h of incubation sample was centrifuged 16 000 g for 10 min. Then supernatant was diluted 2 times with phosphatase dilution buffer: 100 mM NaCl, 50 mM Tris-HCl pH 7.5 supplemented with protease inhibitors. Afterwards, lysate was split into 4 aliquots (35 µL each). All aliquots were supplemented with 10X NEBuffer for Protein MetalloPhosphatases (PMP) and 10X MnCl2 (NEB). The first aliquot (Untreated control) was supplemented with phosphatase inhibitors (PPase inhibitors): 0.5 mM sodium orthovanadate, phosphatase inhibitor cocktail 1 (Sigma, P2850) and phosphatase inhibitor cocktail 2 (Sigma, P5726). They were used at concentrations recommended by the manufacturers. After that 2x Laemmli buffer (with 10% b-Mercaptoethanol) was added and sample was boiled 95 °C for 7 min. The second (PPase inhibitors only) and third (PPase inhibitors + Lambda PPase) aliquots were also supplemented with PPase inhibitors. 2 µL of Lambda Protein Phosphatase (NEB, P0753S) was added to aliquots 3 and 4 (PPase only). Final volume of each sample was 50 µL. Aliquots 2-4 were incubated at 30 °C for 1.5 h. After incubation, 2xLaemmli buffer (with 10% b-Mercaptoethanol) was added 1:1 ratio and samples were incubated at 95 °C for 7 min.
Full text: Click here
Publication 2024

Top products related to «Protein phosphatase inhibitor-2»

Sourced in United States, Germany, China, United Kingdom, Italy, Japan, Sao Tome and Principe, France, Canada, Macao, Switzerland, Spain, Australia, Israel, Hungary, Ireland, Denmark, Brazil, Poland, India, Mexico, Senegal, Netherlands, Singapore
The Protease Inhibitor Cocktail is a laboratory product designed to inhibit the activity of proteases, which are enzymes that can degrade proteins. It is a combination of various chemical compounds that work to prevent the breakdown of proteins in biological samples, allowing for more accurate analysis and preservation of protein integrity.
Sourced in United States, Germany, China, United Kingdom, Morocco, Ireland, France, Italy, Japan, Canada, Spain, Switzerland, New Zealand, India, Hong Kong, Sao Tome and Principe, Sweden, Netherlands, Australia, Belgium, Austria
PVDF membranes are a type of laboratory equipment used for a variety of applications. They are made from polyvinylidene fluoride (PVDF), a durable and chemically resistant material. PVDF membranes are known for their high mechanical strength, thermal stability, and resistance to a wide range of chemicals. They are commonly used in various filtration, separation, and analysis processes in scientific and research settings.
Sourced in United States, Switzerland, Germany, China, United Kingdom, France, Canada, Japan, Italy, Australia, Austria, Sweden, Spain, Cameroon, India, Macao, Belgium, Israel
Protease inhibitor cocktail is a laboratory reagent used to inhibit the activity of proteases, which are enzymes that break down proteins. It is commonly used in protein extraction and purification procedures to prevent protein degradation.
Sourced in United States, United Kingdom, Germany, China, Australia, Switzerland, France, Italy, Canada, Spain, Japan, Belgium, Sweden, Lithuania, Austria, Denmark, Poland, Ireland, Portugal, Finland, Czechia, Norway, Macao, India, Singapore
The Pierce BCA Protein Assay Kit is a colorimetric-based method for the quantification of total protein in a sample. It utilizes the bicinchoninic acid (BCA) reaction, where proteins reduce Cu2+ to Cu+ in an alkaline environment, and the resulting purple-colored reaction is measured spectrophotometrically.
Sourced in United States, China, Germany, United Kingdom, Japan, Belgium, France, Switzerland, Italy, Canada, Australia, Sweden, Spain, Israel, Lithuania, Netherlands, Denmark, Finland, India, Singapore
The BCA Protein Assay Kit is a colorimetric detection and quantification method for total protein concentration. It utilizes bicinchoninic acid (BCA) for the colorimetric detection and quantification of total protein. The assay is based on the reduction of Cu2+ to Cu1+ by protein in an alkaline medium, with the chelation of BCA with the Cu1+ ion resulting in a purple-colored reaction product that exhibits a strong absorbance at 562 nm, which is proportional to the amount of protein present in the sample.
Sourced in United States, Germany, Switzerland, China, Japan, Italy, Canada, Macao, Denmark, Hungary, India, Sao Tome and Principe, Spain, Ireland, United Kingdom
The Phosphatase inhibitor cocktail is a laboratory product designed to inhibit the activity of phosphatase enzymes. Phosphatases play a crucial role in various cellular processes, and their inhibition can be valuable in biological research and analysis.
Sourced in United States, Germany, United Kingdom, Switzerland, Japan, China, Spain, Australia
Phosphatase inhibitor cocktail 2 is a solution containing a combination of phosphatase inhibitors. It is designed for use in the inhibition of phosphatase enzymes during protein extraction and purification procedures.
Sourced in United States, Germany, China, Australia, France, United Kingdom, Canada, Japan
Halt Protease and Phosphatase Inhibitor Cocktail is a ready-to-use solution designed to inhibit a broad spectrum of proteases and phosphatases during protein extraction and purification. It is formulated to prevent degradation of proteins by proteolytic enzymes and dephosphorylation by phosphatases.
Sourced in United States, China, Germany, United Kingdom, Canada
Protease and phosphatase inhibitor cocktail is a laboratory product designed to inhibit the activity of proteases and phosphatases in biological samples. It is used to prevent the degradation of proteins during sample preparation and analysis.
Sourced in United States, Germany, China, United Kingdom, Sao Tome and Principe, Italy, France, Switzerland
Protease and phosphatase inhibitor cocktails are laboratory reagents designed to prevent the degradation of proteins during sample preparation and analysis. These cocktails contain a combination of small-molecule inhibitors that target a variety of proteases and phosphatases, ensuring the preservation of the integrity and functionality of the proteins of interest.

More about "Protein phosphatase inhibitor-2"

Protein Phosphatase Inhibitor-2, also known as Inhibitor-2 (I-2) or PPP1R2, is a regulatory protein that plays a crucial role in the regulation of cellular processes.
This protein inhibits the activity of protein phosphatase enzymes, particularly protein phosphatase 1 (PP1), which is involved in various cellular functions such as glycogen metabolism, transcription, and cell cycle control.
Inhibitor-2 binds to the catalytic subunit of PP1, preventing its activity and leading to the phosphorylation of PP1 substrates.
This process helps maintain the balance between phosphorylation and dephosphorylation within the cell, which is essential for proper cellular function.
Dysregulation of Protein Phosphatase Inhibitor-2 has been implicated in various pathological conditions, including diabetes, cancer, and neurological disorders.
Understanding the functional role and regulation of this inhibitor is crucial for developing targeted therapeutic strategies.
In research, Protein Phosphatase Inhibitor-2 is often studied in conjunction with other related proteins and compounds, such as Protease inhibitor cocktail, PVDF membranes, Pierce BCA Protein Assay Kit, BCA protein assay kit, Phosphatase inhibitor cocktail, Phosphatase inhibitor cocktail 2, Halt Protease and Phosphatase Inhibitor Cocktail, and Protease and phosphatase inhibitor cocktails.
These tools and reagents are commonly used to investigate the activity, regulation, and effects of Protein Phosphatase Inhibitor-2 in cellular and biochemical assays.
Reserchers may also use AI-driven platforms like PubCompare.ai to enhance their research reproducibility and accuracy by locating the best protocols from literature, pre-prints, and patents through seamless comparisons and AI-powered insights.
This can improve research efficiency and confidence in the findings related to Protein Phosphatase Inhibitor-2 and its role in various biological processes and pathological conditions.